Research progress on post-translational modification of proteins and cardiovascular diseases

XueLi Cheng1,2, Kai Wang2, Yan Zhao2

  • 1Key Laboratory of Birth Regulation and Control Technology of National Health Commission of China, Shandong Provincial Maternal and Child Health Care Hospital affiliated to Qingdao University, Jinan, 250014, Shandong, China.

Cell Death Discovery
|July 28, 2023
PubMed

Insights

Cardiovascular diseases (CVDs) are linked to epigenetic changes, specifically post-translational modifications (PTMs). Understanding these reversible protein alterations is key to developing new CVD treatments.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiology

Background:

  • Cardiovascular diseases (CVDs) pose significant global health risks.
  • Epigenetic modifications, including post-translational modifications (PTMs), are increasingly recognized in CVD pathogenesis.
  • PTMs like phosphorylation, acetylation, and newly discovered acylations are crucial for cardiovascular system function.

Purpose of the Study:

  • To review the mechanisms of common PTMs involved in cardiovascular disease.
  • To highlight the role of novel acylation modifications in CVD.

Main Methods:

  • Literature review of studies on PTMs and CVDs.
  • Focus on advancements in high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) for PTM discovery.

Main Results:

  • Various PTMs, including phosphorylation, glycosylation, methylation, and acetylation, are implicated in CVDs.
  • Novel acylation modifications (propionylation, crotonylation, butyrylation, succinylation, lactylation, isonicotinylation) have been identified.
  • Protein conformational changes due to PTMs can alter function and contribute to CVDs.

Conclusions:

  • PTMs play a critical role in the development and progression of cardiovascular diseases.
  • The reversibility of PTMs offers potential therapeutic targets for CVDs.
  • Continued research into PTMs, especially novel acylations, is essential for understanding and treating CVDs.

Related Concept Videos

Protein Modifications in the RER01:26

Protein Modifications in the RER

Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.3K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.9K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
21
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
119
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.5K
Protein Glycosylation01:25

Protein Glycosylation

Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
7.0K